Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Danner, Rebecca ^a   Chaudhari, Snehal N ^a   Rosenberger, John ^a   Surls, Jacqueline ^b   Richie, Thomas L ^a   Brumeanu, Teodor Doru ^b   Casares, Sofia ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR4 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR GAMMA; TETANUS TOXOID; HLA ANTIGEN CLASS 2; HOMEODOMAIN PROTEIN; IL2RG PROTEIN, MOUSE; IMMUNOGLOBULIN; RAG 1 PROTEIN; RAG-1 PROTEIN; TETANUS TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; T LYMPHOCYTE; TETANUS PROPHYLAXIS; ANIMAL; BLOOD; C57BL MOUSE; CD8+ T LYMPHOCYTE; CYTOLOGY; GENE REARRANGEMENT; IMMUNIZATION; IMMUNOLOGY; KINETICS; LYMPHOID TISSUE; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL; NONOBESE DIABETIC MOUSE; REGULATORY T LYMPHOCYTE;

MUS;

ANIMALS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOMEODOMAIN PROTEINS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULINS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; KILLER CELLS, NATURAL; KINETICS; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TETANUS TOXIN;

EID: 79956073079     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019826     Document Type: Article

References (51)

1. Torbett BE, Picchio G, Mosier DE, (1991) Hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunol Rev 124: 139-164.
2. Mosier DE, Gulizia RJ, Baird SM, Wilson DB, (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335: 256-259.
3. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, et al. (1988) The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241: 1632-1639.
4. Pflumio F, Lapidot T, Murdoch B, Patterson B, Dick JE, (1993) Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int Immunol 5: 1509-1522.
5. Huppes W, De Geus B, Zurcher C, Van Bekkum DW, (1992) Acute human vs. mouse graft vs. host disease in normal and immunodeficient mice. Eur J Immunol 22: 197-206.
6. Bosma GC, Custer CR, Bosma MJ, (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530.
7. Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM, (1990) Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 172: 1055-1063.
8. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, et al. (1992) Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 79: 1704-1711.
9. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, et al. (1995) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-SCID mice. J Immunol 154: 180-191.
10. Hesselton RM, Greiner DL, Mordes JP, Rajan TV, Sullivan JL, et al. (1995) High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSzscid/scid mice. J Infect Dis 172: 974-982.
11. Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, et al. (1996) Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 2: 1329-1337.
12. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, et al. (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor g chain. Immunity 2: 223-238.
13. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. (2002) NOD/SCID/γ(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182.
14. Yahata T, Ando K, Nakamura Y, Ueyama Y, Shimamura K, et al. (2002) Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-SCID, IL-2 receptor γ null mice. J Immunol 169: 204-209.
15. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, et al. (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-107.
16. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, et al. (2005) Human lymphoid and myeloid cell development in NOD/LtSz-SCID IL2Rγ null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174: 6477-6489.
17. Legrand N, Weijer K, Spits H, (2006) Experimental models to study development and function of the human immune system in vivo. J Immunol 176: 2053-2058.
18. Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, et al. (2009) The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gcnull (NOG) mice (hu-HSC NOG mice). Int Immunol 21: 843-858.
19. Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, et al. (2010) Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cells engraftment in 3 immunodeficient strains of mice bearing the IL2Rgamma(null) mutation. Clin Immunol 135: 84-98.
20. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, et al. (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106: 1565-1573.
21. Matsumura T, Kametani Y, Ando K, Hirano Y, Katano I, et al. (2003) Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp Hematol 31: 789-797.
22. Baenziger S, Tussiwand R, Schlaepfer E, Mazzucchelli L, Heikenwalder M, et al. (2006) Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci USA 103: 15951-15956.
23. Takahama Y, Nittaa T, Ripena AM, Nittaa S, Muratab S, et al. (2010) Role of thymic cortex-specific self-peptides in positive selection of T cells. Sem Immunol 22: 287-293.
24. Fairfax KA, Kallies A, Nutt SL, Tarlinton DM, (2008) Plasma cell development: From B-cell subsets to long-term survival niches. Sem Immunol 20: 49-58.
25. Lan P, Tonomura N, Shimizu A, Wang S, Yang YG, (2006) Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34-cell transplantation. Blood 108: 487-492.
26. Rajesh D, Zhou Y, Jankowska-Gan E, Roenneburg DA, Dart ML, et al. (2010) Th1 and Th17 immunocompetence in humanized NOD/SCID/γc-KO mice. Human Immunol 71: 551-559.
27. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, et al. (2009) Dengue Virus Infection and Virus-Specific HLA-A2 Restricted Immune Responses in Humanized NOD-scid IL2rcnull Mice. PLoS One 4: e7251.
28. Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, et al. (2009) Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med 206: 1423-1434.
29. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, et al. (2010) Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice. Proc Natl Acad Sci USA 107: 13022-13027.
30. Colovai AI, Giatzikis C, Ho EK, Farooq M, Suciu-Foca N, et al. (2004) Flow cytometric analysis of normal and reactive spleen. Modern Pathology 17: 918-927.
31. Nazarov-Stoica C, Surls J, Bona C, Casares S, Brumeanu T, (2009) CD28 signaling in T regulatory precursors requires P56lck and rafts integrity to stabilize the Foxp3 message. J Immunol 182: 102-110.
32. Mercer F, Kozhaya L, Unutmaz D, (2010) Expression and Function of TNF and IL-1 Receptors on Human Regulatory T Cells. PLoS ONE 5: e8639.
33. Casares S, Inaba K, Brumeanu TD, Steinman R, Bona CA, (1997) Antigen presentation by dendritic cells following immunization with DNA encoding a MHC class-II restricted epitope. J Exp Med 186: 1481-1486.
34. Velásquez-Lopera MM, Correa LA, García LF, (2008) Human spleen contains different subsets of dendritic cells and regulatory T lymphocytes. Clin Exp Immunol 154: 107-114.
35. Chung A, Rollman E, Johansson S, Kent SJ, Stratov I, (2008) The utility of ADCC responses in HIV infection. Curr HIV Res 6: 515-519.
36. Mamoni RL, Blotta MH, (2006) Flow-cytometric analysis of cytokine production in human paracoccidioidomycosis. Cytokine 35: 207-216.
37. Schroeder HW, Cavacini L, (2010) Structure and function of immunoglobulins. J Allergy Clin Immunol 125: S41-52.
38. Wortis HH, (1971) Immunological responses of 'nude' mice. Clin Exp Immunol 8: 305-317.
39. Klein L, Kyewski B, (2000) Self-antigen presentation by thymic stromal cells: a subtle division of labor. Curr Opin Immunol 12: 179-186.
40. Liu YJ, (2006) A unified theory of central tolerance in the thymus. Trends Immunol 27: 215-221.
41. Greinix HT, Ladiges WC, Graham TC, Maslan S, Raff RF, et al. (1991) Late failure of autologous marrow grafts in lethally irradiated dogs given anti class-II monoclonal antibody. Blood 78: 2131-2138.
42. Greinix HT, Storb R, Bartelmez SH, (1992) Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules. Blood 80: 1950-1956.
43. Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, et al. (2002) The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 99: 4200-4206.
44. Rudd CE, Janssen O, Cai YC, da Silva AJ, Prasad KV, (1994) Two-step TCRzeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today 15: 225-234.
45. Miller RA, Garcia G, Kirk CJ, Witkowski JM, (1997) Early activation defects in T lymphocytes from aged mice. Immunol Rev 160: 79-90.
46. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, et al. (2004) Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173: 5361-5371.
47. Coffman RL, Lebman DA, Rothman P, (1993) Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 54: 229-270.
48. Ettinger R, Sims GP, Fairhurst AM, Robbins R, da Silva YS, et al. (2005) IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 175: 7867-7879.
49. Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, et al. (2002) A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
50. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, et al. (1989) IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 86: 7547-7551.
51. Casares S, Hurtado A, McEvoy RC, Sarukhan A, von Boehmer H, Brumeanu TD, (2002) Downregulation of diabetogenic CD4 T cells by a soluble, dimeric MHC class II-peptide chimera. Nature Immunol 3: 383-392.